Journal of Korean Medicine for Obesity Research (한방비만학회지)

The Society of Korean Medicine for obesity Research (한방비만학회)
권호 표지
DOI QR코드

DOI QR Code

Effects of Pharmacoacupuncture for Obesity: A Systematic Review and Meta-Analysis

비만에 대한 약침의 효과: 체계적 문헌고찰과 메타분석

  • Received : 2023.10.19
  • Accepted : 2023.11.17
  • Published : 2023.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Obesity is a chronic metabolic disease that negatively affects quality of life and health. It is associated with various disease and its prevalence is on the rise. Although various treatments for obesity are used, they have several adverse effects. Pharmacoacupuncture is a widely used method for treating various diseases and has the advantage of having fewer adverse effects. This systematic review and meta-analysis evaluate the efficacy of pharmacoacupuncture in treating obesity. Methods: Eight electronic databases were searched from their inception to August 2023. Only randomized controlled trials were included in this review. Intervention groups included pharmacoacupuncture. Control groups had no limitation. The primary outcome was body mass index (BMI), and the secondary outcomes were body weight (BW), waist circumference (WC), and adverse effects. Continuous outcome data were presented as mean differences (MD) with 95% confidence intervals (CI). Results: Four randomized controlled trials (RCTs) involving 139 participants were included in this systematic review and meta-analysis. Results revealed that BMI ((MD)=-0.98, 95% CI -1.84 to -0.11, Z=2.22, P=0.03, I2=0%), WC (MD=-4.29, 95% CI -7.51 to -1.08, Z=2.62, P=0.009, I2=38%) were significantly improved in the intervention groups compared to control groups. Adverse effects were reported in two studies. Conclusions: This systematic review and meta-analysis suggests that pharmacoacupuncture is an effective and safe therapy for simple obesity. Further detailed studies should be conducted on effects of pharmacoacupuncture for obesity to increase reliability.

Keywords

References

  1. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004 ; 89(6) : 2583-9.  https://doi.org/10.1210/jc.2004-0535
  2. Fontaine KR, Barofsky I. Obesity and health-related quality of life. Obes Rev. 2001 ; 2(3) : 173-82.  https://doi.org/10.1046/j.1467-789x.2001.00032.x
  3. Nam GE, Kim YH, Han K, Jung JH, Rhee EJ, Lee WY, et al. Obesity fact sheet in Korea, 2020: prevalence of obesity by obesity class from 2009 to 2018. J Obes Metab Syndr. 2021 ; 30(2) : 141-8.  https://doi.org/10.7570/jomes21056
  4. Haslam DW, James WP. Obesity. Lancet. 2005 ; 366(9492) : 1197-209.  https://doi.org/10.1016/S0140-6736(05)67483-1
  5. Webb VL, Wadden TA. Intensive lifestyle intervention for obesity: principles, practices, and results. Gastroenterology. 2017 ; 152(7) : 1752-64.  https://doi.org/10.1053/j.gastro.2017.01.045
  6. Muller TD, Bluher M, Tschop MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov. 2022 ; 21(3) : 201-23.  https://doi.org/10.1038/s41573-021-00337-8
  7. Gloy VL, Briel M, Bhatt DL, Kashyap SR, Schauer PR, Mingrone G, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and metaanalysis of randomised controlled trials. BMJ. 2013 ; 347 : f5934. 
  8. Korea Institute of Oriental Medicine. Korean medicine clinical practice guideline: obesity. Human Culture Arirang. 2018 : 56-163. 
  9. Woo JA, Nam YJ, Park YJ, Kwon YK. Review of recent clinical trials for depression in traditional Chinese medicine-based on randomized controlled trials and systematic reviews. J Physiol Pathol Korean Med. 2015 ; 29(6) : 458-66.  https://doi.org/10.15188/kjopp.2015.12.29.6.458
  10. Kim SY, Shin IS, Park YJ. Effect of acupuncture and intervention types on weight loss: a systematic review and meta-analysis. Obes Rev. 2018 ; 19(11) : 1585-96.  https://doi.org/10.1111/obr.12747
  11. Kim MW, Song YK, Lim HH. Study of experimentations and clinical trials' trends for obesity treatment using pharmacupuncture. J Korean Med Obes Res. 2011 ; 11(1) : 47-60. 
  12. Jeong SH, Kim HS, Shin WC, Cho JH, Chung WS, Song MY. Trend of pharmacopuncture treatment on obesity: recent 10 years. J Korean Med Obes Res. 2022 ; 22(2) : 147-57.  https://doi.org/10.15429/jkomor.2022.22.2.147
  13. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011 ; 343 : d5928. 
  14. Song MY, Park JH, Lee JH, Kim HJ, Lee MJ. The efficacy and safety of ephedra and green tea mesotherapy on localized fat. J Korean Med Obes Res. 2007 ; 7(1) : 71-85. 
  15. Lee AR, Cho YJ, Jung WS, Yang YJ, Song MY. The effects of Sobi-eum (Xiaofei-yin) mesotherapy on abdominal fat distribution. J Korean Med Rehabil. 2009 ; 19(2) : 261-73. 
  16. Kim JH, Shin MS, Choi SW, Song BY, Yook TH. The effect of Mahuang (Ephedra sinica Stapf)-Chuanwu (Aconitum carmichaeli Debx) pharmacopuncture treatment in obese patients. J Acupunct Res. 2009 ; 26(5) : 77-83. 
  17. Kim EJ, Brodsky M, Cho JH, Cho YJ, Song MY. Effect of Gocho extract mesotherapy on regional fat loss in obese Korean women. J Korean Med. 2011 ; 32(6) : 30-40. 
  18. World Health Organization, Regional Office for the Western Pacific. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney : Health Communications Australia. 2000. 
  19. Nuttall FQ. Body mass index: obesity, BMI, and health: a critical review. Nutr Today. 2015 ; 50(3) : 117-28.  https://doi.org/10.1097/NT.0000000000000092
  20. Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, et al. Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes. 2008 ; 32(6) : 959-66.  https://doi.org/10.1038/ijo.2008.11
  21. Kim SM, Kim SS, Yoon SJ, Shim KW, Choi HJ, Kim KM, et al. What is the best simple anthropometric indexes of abdominal visceral fat in obese patients? J Korean Soc Study Obes. 1998 ; 7(2) : 157-68. 
  22. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med. 2008 ; 168(15) : 1617-24.  https://doi.org/10.1001/archinte.168.15.1617
  23. Yoon YS, Oh SW. Optimal waist circumference cutoff values for the diagnosis of abdominal obesity in Korean adults. Endocrinol Metab (Seoul). 2014 ; 29(4) : 418-26.  https://doi.org/10.3803/EnM.2014.29.4.418
  24. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008 ; 359(20) : 2105-20. https://doi.org/10.1056/NEJMoa0801891
  25. Kang J. Electroacupuncture for obesity: a systematic review and meta-analysis [Master's thesis]. Kyung Hee University; 2023. 
  26. Zhang RQ, Tan J, Li FY, Ma YH, Han LX, Yang XL. Acupuncture for the treatment of obesity in adults: a systematic review and meta-analysis. Postgrad Med J. 2017 ; 93(1106) : 743-51.  https://doi.org/10.1136/postgradmedj-2017-134969
  27. Lim CS, Park WP, Jang SB, Choi YC, Park DI, Kwon KR, et al. Clinical studies of sweet bee venom to the effect of abdominal fat accumulation. J Pharmacopunct. 2008 ; 11(2) : 55-62.  https://doi.org/10.3831/KPI.2008.11.2.055
  28. Choi WJ, Kim MH, Park N, Chung JY, Park SJ, Yang WM. Effect and mechanism of Magnolia officinalis pharmacopuncture for treating localized fat via network pharmacology and experimental study. Integr Med Res. 2023 ; 12(2) : 100948. 
  29. Sun X, Han F, Lu Q, Li X, Ren D, Zhang J, et al. Empagliflozin ameliorates obesity-related cardiac dysfunction by regulating Sestrin2-mediated AMPK-mTOR signaling and redox homeostasis in high-fat diet-induced obese mice. Diabetes. 2020 ; 69(6) : 1292-305.  https://doi.org/10.2337/db19-0991
  30. Ha J, Lee S. Role of AMPK in the regulation of cellular energy metabolism. J Korean Endocr Soc. 2010 ; 25(1) : 9-17.  https://doi.org/10.3803/jkes.2010.25.1.9
  31. Lee H, Kim MH, Jin SC, Choi Y, Nam YK, Yang WM. LIPOSA pharmacopuncture, a new herbal formula, affects localized adiposity by regulating lipid metabolism in vivo. Exp Ther Med. 2021 ; 22(5) : 1290. 
  32. Nam YK, Park SJ, Kim MH, Choi Y, Yang WM. Pharmacopuncture of Taraxacum platycarpum extract reduces localized fat by regulating the lipolytic pathway. Biomed Pharmacother. 2021 ; 141 : 111905. 
  33. Youn DH, Kang JD, Na CS. Effects of herbal acupuncture (Ephedra sinica and green tea) at Umnungchon(SP9) and Pungnyung(ST40) in obese rats induced by high fat diet. Korean J Meridian Acupoint. 2004 ; 21(1) : 51-60. 
  34. Song MY, Chung SH, Lee JS, Kim SS, Shin HD. Effects of Sobieum (Xiaofeiyin) on weight, plasma, and UCP mRNA expressions in Zucker rats. J Korean Med Rehabil. 2001 ; 11(2) : 75-83. 
  35. Kang KH. Effects of Mahuang-Chuanwu (mahwang-cheonoh) pharmacopuncture solution on adipocyte differentiation and gene expression in 3T3-L1 adipocytes. Korean J Acupunct. 2014 ; 31(4) : 168-78.  https://doi.org/10.14406/acu.2014.025
  36. Jang HJ, Lee HS, Lee JM. Effects of Hagocho (Prunella vulgaris L.), Gamgook (Chrysanthemum indicum L.) and Galgeun (Pueraria Radix) aqua-acupuncture at gokji (LI-11) and Joksamri (ST-36) on lowering lipid effect, oxidative capacity, concentration of TNF-α, IL-6, leptin and histological consideration in hyperlipidemic rat. J Meridian Acupoint. 2007 ; 24(4) : 201-19.